GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine

GLP-1受体激动剂用于减肥和提高生育能力:社交媒体和网络认知与循证医学的比较

阅读:1

Abstract

BACKGROUND: The injectable glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drugs are commonly used for weight loss among reproductive-aged women but the perception of their impact on fertility is not clear among the public. OBJECTIVES: The purpose of this review was to compare scientific literature to social media discourse and online search pertaining to the potential impact of GLP-1 RAs on female fertility. METHODS: Group 1 included 3 social media platforms, each of which required a different data collection method. For Reddit, VADER (Communalytic ®) was used as a sentiment analyzer and for Twitter and TikTok, we performed a manual search for posts and scored them using an objective internal scale. Group 2 included the online search engine Google Trends. Group 3 consisted of medical literature search by PubMed. All sentiments of posts/comments/articles were graded as: "Positive, Neutral, or Negative" and compared among groups. RESULTS: In Groups 1 and 2, scores showed a significantly more Positive than Neutral, and more Neutral than Negative sentiments. In Group 3, among the 52 original studies found on PubMed in women with polycystic ovary syndrome (PCOS), they all had Positive sentiments. In Groups 1, 2, and 3, there was a strong positive correlation among all sentiments (r2 = 0.83). Even though all 3 social media platforms had the majority of posts with a Positive sentiment and correlated with Google Trends posts and with PubMed studies in women with PCOS (r2 = 0.74), there was a lack of PubMed studies pertaining to the effect of GLP-1 RA in women without PCOS. CONCLUSION: The Positive sentiments among women without PCOS is not justified by evidence-based medicine and there is a clear need for studies pertaining to this topic.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。